Table 2.

The major outcomes of the included patients

Variables	Value
In-hospital mortality, n (%)	82 (30.3%)
Cause of death
Multiple organ failure, n (%)	40 (48.8%)
Heart failure, n (%)	35 (42.7%)
Hemorrhagic shock, n (%)	2 (2.4%)
Sepsis, n (%)	5 (6.1%)
Reoperation, n (%)	17 (6.3%)
AKI, n (%)	222 (81.9%)
Stage of AKI
Stage 1, n (%)	102 (40.2%)
Stage 2, n (%)	34 (12.5%)
Stage 3, n (%)	84 (29.2%)
Use of CRRT, n (%)	50 (18.5%)
Use of PE/BA, n (%)	11 (14.1%)
Use of IABP, n (%)	1 (0.4%)
Use of ECMO, n (%)	7 (2.6%)
Use of vasoactive agent, n (%)	173 (63.8%)
Mechanical ventilation time, mean ± SD (days)	3.3 ± 5.7
The amount of blood transfusion, mean ± SD (U)	34.8 ± 43.3
In hospital time, mean ± SD (days)	19.8 ± 10.7
ICU stay time, mean ± SD (days)	6.6 ± 6.3
Onset of severe hyperbilirubinemia, mean ± SD (days)	2.8 ± 1.3

AKI Acute kidney injury, BA Bilirubin adsorption, CRRT Continuous renal replacement therapy, ECMO Extracorporeal membrane oxygenation, IABP Intra-aortic balloon pump, ICU Intensive care unit, PE Plasma exchange